Featured Research
from universities, journals, and other organizations
Ebola vaccine effective in a single dose
Date:
April 8, 2015
Source:
University of Texas Medical Branch at Galveston
Summary:
Medical researchers have developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. During 2014, the outbreak of the West African Makona strain of Ebola Zaire virus killed nearly 10,000 and caused worldwide concern. With increasing population growth in West Africa, the frequency of contact between humans and natural Ebola virus hosts such as bats will likely rise, potentially leading to more catastrophic outbreaks.
An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. These findings are detailed in the new edition of Nature.
Related Articles
During 2014, the outbreak of the West African Makona strain of Ebola Zaire virus killed nearly 10,000 and caused worldwide concern. With increasing population growth in West Africa, the frequency of contact between humans and natural Ebola virus hosts such as bats will likely rise, potentially leading to more catastrophic outbreaks.
Many vaccine approaches have shown promise in being able to protect nonhuman primates against Ebola Zaire. In response to the Ebola Zaire outbreak, several of these vaccines have been fast tracked for human use.
One of those vaccines, developed by UTMB and Profectus, has been undergoing testing in the Galveston National Laboratory, the only fully operational Biosafety Level 4 laboratory on an academic campus in the U.S.
"These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks," said Thomas Geisbert, UTMB professor of Mmicrobiology and Iimmunology. "We are excited at the possibility of helping develop a way to stop this deadly disease. We have a lot of more work to accomplish but it's important to note that this is a big step."
The research team developed a vaccine effective against Ebola Zaire with a single dose in a nonhuman primate model. This new vaccine employs a virus not harmful to humans called vesicular stomatitis virus that had a part of the Ebola virus inserted into it. This "Trojan horse" vaccine safely triggered an immune response against Ebola Zaire.
To address any possible safety concerns associated with this vaccine, the team developed two next generation candidate vaccines that contain further weakened forms of the vaccine. Both of these vaccines produced an approximately ten-fold lower level of virus in the blood compared to the first generation vaccine.
"It was not known whether any of these vaccines could provide protection against the new outbreak West African Makona strain of Ebola Zaire currently circulating in Guinea," said John Eldridge, Chief Scientific Officer-Vaccines at Profectus Biosciences, Inc. "Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virus."
Both weakened vaccines have features of the Mayinga strain of Ebola virus, as do most other candidate Ebola Zaire vaccines currently under evaluation. The original 1976 Mayinga strain and the new West African Makona strain are quite similar. The researchers said it was important to test their candidate vaccines on the Makona strain to ensure that even small differences between the strains didn't impact the effectiveness of the vaccine.
Story Source:
The above story is based on materials provided by University of Texas Medical Branch at Galveston. Note: Materials may be edited for content and length.
Journal Reference:
- Chad E. Mire, Demetrius Matassov, Joan B. Geisbert, Theresa E. Latham, Krystle N. Agans, Rong Xu, Ayuko Ota-Setlik, Michael A. Egan, Karla A. Fenton, David K. Clarke, John H. Eldridge, Thomas W. Geisbert. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus. Nature, 2015; DOI: 10.1038/nature14428
Cite This Page:
Share This
More From ScienceDaily
More Health & Medicine News
Wednesday, April 8, 2015
Featured Research
from universities, journals, and other organizations
Autism's Early Neuronal 'Neighborhood'
Apr. 8, 2015 — The first ever systematic look at connections between the entire cerebral cortex and the cerebellum have been gained by researchers using fMRI brain imaging, and its findings provide another piece in ... full story
- Autism's Early Neuronal 'Neighborhood'
- Alternating Antibiotics Kills Resistant Bacteria
- Distance Running May Signal Desirable Male Genes
- Allergy Drug Inhibits Hepatitis C in Mice
- Worms, Germs Lead to Better Immune Function
- Tumor Cells Mimic Blood Vessels, Spread Cancer?
- Ebola Vaccine Effective in a Single Dose
- 'Wasabi Receptor' Informs Pain Drug Development
- Antibody Therapy: Promise in Suppressing HIV
- Pesticide Exposure: Heightened Heart Disease Risk
newer top stories | older top stories
Breaking News:
Strange & Offbeat Stories
Health & Medicine
- Anesthetic Gases Raise Earth's Temperature (a Little) While You Sleep
- Gotcha! Ultra-Realistic Robot Proves There's More Than One Way to Scare a Fish
- Sound Separates Cancer Cells from Blood Samples
- Near-Death Brain Signaling Accelerates Demise of the Heart
- Stress and Obesity: Your Family Can Make Your Fat
Mind & Brain
- Don't Blame Kids If They Do Not Enjoy School, Study of Twins Suggests
- Nearly One in Ten U.S. Adults Have Impulsive Anger Issues and Access to Guns
- New Emotion Recognition Model: Humans Perceive Feelings of Others Via Pattern Recognition
- Breastfeeding Women and Sex: Higher Sex Drive or Relationship Management?
- Internet-Style 'Local Area Networks' in Cerebral Cortex of Rats
Living & Well
- Don't Blame Kids If They Do Not Enjoy School, Study of Twins Suggests
- New Emotion Recognition Model: Humans Perceive Feelings of Others Via Pattern Recognition
- Element of Surprise Helps Babies Learn
- First Perfume Which Smells Better the More You Sweat
- Poses of Power Are Less Powerful Than We Thought
In Other News
... from NewsDaily.com
Science News
- Dust-covered ice glaciers found on Mars
- Jeff Bezos' rocket company to begin suborbital test flights this year
- Scientists restore the good name of Brontosaurus
- New aluminum battery for smartphones can be charged in a minute
- Robotic glove could help stroke survivors
Health News
- Canada bird flu virus in Ontario similar to U.S. strain
- Injury prevention programs unpopular with high school coaches
- Celladon to report results of its gene therapy for heart failure: CEO
- Midlife arts, crafts and socializing tied to better late-life cognition
- Common painkiller may not ease lower back pain or osteoarthritis
Environment News
- In drought, Californians lacking water meters let it flow
- Pressing play to learn how climate change can impact indigenous cultures
- Is 'Game of Thrones' aiding the global debate on climate change?
- Enel Green Power looks to Asia for next phase of growth
- APG adds support to BP climate change resolution
Technology News
- Testimony kicks off in ex-Goldman programmer code theft trial
- Zynga CEO resigns, founder Mark Pincus steps in
- Court questions Google on patent values in Microsoft case
- Digital Ally shares rise in wake of South Carolina shooting
- U.S. FCC imposes $25 million fine on AT&T over customer data breach
No comments:
Post a Comment
Please leave a comment-- or suggestions, particularly of topics and places you'd like to see covered